NYSE:KKRCapital Markets
KKR (KKR) Could Be 15% Overvalued On Allyntra Launch
KKR (KKR) has drawn fresh attention after unveiling Allyntra, a new precision engineered solutions platform focused on medical technology and advanced surgical applications. The platform is built around existing portfolio company Precipart and supported by additional committed capital.
See our latest analysis for KKR.
At a share price of $96.91, KKR has seen a modest 7 day share price return of 0.98% and a 30 day share price return of 0.70%. The year to date share price return is down 24.82%,...